Company news
Endonovo Therapeutics, Inc. news in 2018
Endonovo Therapeutics, Inc.'s news releases, calls and decks from 2018, newest first.
Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
December 18, 2018
Endonovo Expands SofPulse Commercialization
December 13, 2018
Endonovo Therapeutics Announces Strategic Relationship with US Authentic Trading Company
December 3, 2018
Endonovo Therapeutics Announces Complimentary New Product
November 8, 2018
Endonovo Therapeutics Provides Update on Liver Study
October 22, 2018
Endonovo Therapeutics Signs Distribution Agreement For National Distribution of Sofpulse® Electroceutical™ System
August 14, 2018
Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
June 14, 2018
Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical™ SofPulse®
May 9, 2018
Endonovo Therapeutics Highlights Feasibility Study Results of Its Electroceutical Therapy in Reducing Proteinuria in Chronic Kidney Disease Patients
May 1, 2018
Endonovo Therapeutics Inc. to Move Forward with a Clinical Research Study Conducted by the Regents of the University of New Mexico
April 18, 2018
Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
February 12, 2018
Endonovo Reports Pre-Clinical Data Demonstrating Immunotronics™ Reduced Infarct Size and Inhibited Fibrosis following Myocardial Infarction
February 1, 2018
Endonovo Announces First Commercial Sales for SofPulse Wearable Electroceutical for Post-Operative Pain and Edema
January 22, 2018
Endonovo Therapeutics Provides Corporate Update and 2018 Outlook
January 16, 2018
Endonovo Therapeutics Engages ShareIntel, A Leader In Shareholder Intelligence Services To Investigate Market Maker and Clearing Firm Irregularities
January 11, 2018